WASHINGTON, Dec. 20 -- Blood Advances, a medical journal that says it covers all aspects of hematology, including disorders of leukocytes, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology and hematologic oncology from the American Society of Hematology, published research articles on the following topics in its Dec. 28, 2021 edition:

* Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products